| H-MET-SER-ARG-PRO-ALA-CYS-PRO-ASN-ASP-LYS-TYR-GLU-OH |
H-MET-SER-ARG-PRO-ALA-CYS-PRO-ASN-ASP-LYS-TYR-GLU-OH |
207553-92-2 |
| THROMBIN (B 147-158) (HUMAN) |
THROMBIN (B 147-158) (HUMAN) |
207553-42-2 |
| HS014 |
HS014 |
207678-81-7 |
| N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-L-tyrosine |
N-芴甲氧羰基-2,6-二甲基-L-酪氨酸 |
206060-54-0 |
| FMOC-TYR-ALA-DIAZOMETHYLKETONE |
FMOC-TYR-ALA-DIAZOMETHYLKETONE |
205763-22-0 |
| HYPERCALCEMIA OF MALIGNANCY FACTOR (1-37) (HUMAN, RAT) |
PTH-RELATED PROTEIN (1-37) (HUMAN, RAT) |
206010-80-2 |
| H-D-ALA-GLN-OH |
D-丙氨酰-L-谷氨酰胺 |
205252-36-4 |
| FMOC-L-PENTAFLUOROPHENYLALANINE |
FMOC-L-2,3,4,5,6-五氟苯丙氨酸 |
205526-32-5 |
| Orexin A (bovine, human, mouse, rat) |
促食素A |
205640-90-0 |
| Liraglutide |
利拉鲁肽 |
204656-20-2 |
| BOC-L-4-CARBAMOYLPHE |
BOC-L-4-CARBAMOYLPHE |
205126-71-2 |
| Osteostatin amide (human) |
THR-ARG-SER-ALA-TRP-LEU-ASP-SER-GLY-VAL-THR-GLY-SER-GLY-LEU-GLU-GLY-ASP-HIS-LEU-SER-ASP-THR-SER-THR-THR-SER-LEU-GLU-LEU-ASP-SER-ARG-NH2 |
204383-55-1 |
| H-ARG-LYS-GLY-ASP-ILE-LYS-SER-TYR-PNA |
H-ARG-LYS-GLY-ASP-ILE-LYS-SER-TYR-PNA |
204450-29-3 |
| AC-TBU-GLY-TBU-GLY-ASN(ME)2-ALA-AMC |
AC-TBU-GLY-TBU-GLY-ASN(ME)2-ALA-AMC |
204909-38-6 |
| ABZ-TBU-GLY-TBU-GLY-ASN(ME)2-ALA-SER-SER-ARG-LEU-3-NITRO-TYR-ARG-OH |
ABZ-TBU-GLY-TBU-GLY-ASN(ME)2-ALA-SER-SER-ARG-LEU-3-NITRO-TYR-ARG-OH |
204909-37-5 |
| DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) |
依多曲肽 |
204318-14-9 |
| PYR-PHE-GLY-NH2 |
PYR-PHE-GLY-NH2 |
203396-25-2 |
| EMP20 |
ERYTHROPOIETIN MIMETIC PEPTIDE SEQUENCE 20 |
203397-62-0 |
| SNX 482 |
R型CAV2.3钙通道阻滞剂 |
203460-30-4 |
| H-SER-LEU-ILE-GLY-LYS-VAL-OH |
PAR-2 (1-6) (HUMAN) |
202933-49-1 |
QQ
微信
